KOWALSKY MATTHEW PAUL (Chief Legal Officer) received a stock award from ENANTA PHARMACEUTICALS INC
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 2 awards
Filed: 2/13/2026ACC: 0002064832-26-000016
Officer· Chief Legal Officer
Since Feb 2026
+3.59K
Net shares
Net buyer
$27.1K
Total sold
0
Open market trades
0B · 0S
3
Total transactions
5.49K acquired · 1.90K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
+1.32K
Price / share
—
Trade value
—
% of position
New position
2/12/2026
0.00→1.32K
Common Stock
Direct
Shares
+4.17K
Price / share
—
Trade value
—
% of position
316.8%
2/12/2026
1.32K→5.49K
Common Stock
Direct
Shares
−1.90K
Price / share
$14.25
Trade value
$27.10K
% of position
34.6%
2/12/2026
5.49K→3.59K
Total
Net shares
+3.59K
Net value
-$27.10K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/12/2026 | A · Award | +1.32K | — | — | New position | 0.00 | 1.32K |
| Common Stock Direct | 2/12/2026 | A · Award | +4.17K | — | — | 316.8% | 1.32K | 5.49K |
| Common Stock Direct | 2/12/2026 | F · Tax Withholding | −1.90K | $14.25 | $27.10K | 34.6% | 5.49K | 3.59K |
| Total | +3.59K | -$27.10K | ||||||
Derivative Transactions0
No derivative transactions reported